Medindia

X

FDA CONSUMER HEALTH INFORMATION - FDA's MedWatch Safety Alerts: July 2010

Saturday, August 21, 2010 Drug News J E 4
Advertisement
SILVER SPRING, Md., Aug. 20 The Food and Drug Administration (FDA) has issued safety alerts about a number of products, including

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

These and other alerts were prompted by reports FDA received from health care professionals and patients through the agency's MedWatch Adverse Event Reporting Program.

Learn more about these safety alerts and what to do if you've used one of the affected products at

http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm221628.htm

Sign up for e-mail notices of new FDA Consumer Updates at

https://service.govdelivery.com/service/subscribe.html?code=USFDA_9

View the FDA Consumer Update RSS feed at http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: consumerinfo@fda.hhs.gov.

CONTACT: Jason Brodsky at 301-796-8234; jason.brodsky@fda.hhs.gov

-- "Miracle Mineral Supplement," which acts like an industrial-strength bleach and causes severe side effects when consumed as directed -- stolen asthma inhalers, which may be contaminated and have appeared in pharmacies -- a product sold as an herbal weight-loss supplement that contains prescription drug ingredients, stimulants, and a controlled substance

SOURCE U.S. Food and Drug Administration
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
U.S. Census Bureau Daily Feature for August 21
S
Jazz Pharmaceuticals Provides Update on FDA Adviso...